thank Valter, and you, operating for today to joining and discuss XXXX our results. you, Thank financial us second quarter everyone,
$X.XX record XX.X% consumer quarter to in was second XXXX totaling as company, increase driver, was $XXX,XXX, a quarter revenue June XXXX. year-over-year compared products $XXX,XXX an a of the for totaling and The XX.X% Branded of million, of revenue sequentially. key growth
Silly eyelash alternatives as eyelashes full half base product comparison quarter and product offers eyelash of George our lash December which line products, customer in product and our revenue lash of XXXX, acquired is of from new of accessories. the a serum branded extensions, year-over-year customer about Silly such Included in various George. we and Kenkoderm for contribution eye acquisition care, and loyal hassle-free line, including a its
and consumer consumer, large George customer XXX,XXX Silly database, Instagram unique well. as XX,XXX over United following in Facebook e-mails. XX,XXX built social George but a has direct includes predominantly sold the only and Silly internationally media is followers not as to States, as well which
its When to products new apply extensions such the $X approximately last non-toxic, lashes, million. easy technology for that neutralized long-wear have could brand, a days. we was are line acquired eyelash and remove revenue Since of leveraging launched create we then, pop-on new to as rate X and XX to
also implemented strategies. marketing We new
a George May only. common in We as and stock, In $XXX,XXX and earnout. marketing, products $XXX,XXX, pleased to new July, Silly sales cash, Silly am announced to future we were acquired George as continues July perform plus on I in result for short confirm order over well, Shopify a of and in alone that
sales can to be product consumer While we with our continue excited fluctuate, acquisition.
just are releasing now Amazon. only Additionally, our lashes we on pop-on
our support In the square and of the of completed capacity side the expansion have. facilities. we invested business, relationships in automated client manufacturing state-of-the-art Texas to room and doubled related that our footage machinery clean in we new our contract We
the During amount that capital back to be we have this half expansion. $XXX,XXX, we completed of some the expenditures in to had the and expect that related the minimal expansion quarter, now number year of remaining the in
validate Due a operations. to for to period facility of quarter, revenue in as restarting we equipment down move shut was our expansion impacted, the and time prior the it to
forward We QX to in and going normalized more QX. expect be revenue
issues which annualized Europe. and to million well. oxidase in well enzyme in as conditions. progress recently headache, We is product, DAOSIN This intolerance, our selling with skin $XX relationship Our STADA Histasolv, supplement, over is revenues migraines, diamine Europe's #X sold histamine cause announced food which treat generating first continues can to gut
this our marketing on launched month. just Histasolv Amazon have and campaign We starting
services customers uniforms, first to distribute product, many to supply Silverseal. leading over its America, provider products Subsequent million and will across flagship and of X a Corporation, Cintas and with service. Silverseal announced the identity agreement Cintas in businesses our to quarter, such corporate to sectors a safety North we public hospitality distribute aid as
and the product. dressing This of As for ideal Silverseal's the Cintas' for for a significant not customers this the are revenue, audience burns, but wounds target partnership us awareness. employees to associated brand also hospital-grade for hydrogel only is
expect quarter first of order We be fourth XXXX. delivered the the Silverseal during to of
increase the $X.X issued of XX% third increase the $X.X recently We and million, revenue XXX% guidance quarter year-over-year, for year-over-year. of an an quarter million, of of over fourth for
At Pulse cellulite to for XXXX, start Our Acoustic flow AbbVie from not still operations. partnership still in the continue launch. of in any and incorporate RESONIC for of from does guidance with we their the positive We are level and pads reduced quarterly QX appearance. getting with revenue close our expected our generating to this revenue supplier on their revenue gel device closely goal achieving cash Rapid team as QX very QX, higher of to we revenue exclusive work expect
the financing we completed week, for dollars proceeds capital to working increase with Silly of This us Lastly, attractive the also for million for our replenish provide earlier a sheet and by we spend spent balance and led this with investment $X.XX will insiders terms. at gross marketing the buy financing brand. inventory George
CFO, the to our Adam? like would over I Drapczuk. that, turn Adam call With to